首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1788318

主動脈復甦性血管內球囊阻斷術的全球市場

Resuscitative Endovascular Balloon Occlusion of the Aorta

出版日期: 2025年08月12日 | 出版商:

Global Industry Analysts, Inc. | 英文 109 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，全球復甦性主動脈血管內球囊阻斷市場規模將達到 3,720 萬美元

2024年，全球主動脈復甦性血管內球囊阻斷市場規模估計為1,250萬美元，預計到2030年將達到3,720萬美元，在2024-2030年的分析期內，複合年成長率為20.0%。心臟麻痹是本報告分析的細分市場之一，預計其複合年成長率為18.3%，到分析期結束時達到2,170萬美元。主動脈阻斷細分市場在分析期間的複合年成長率估計為23.0%。

美國市場規模估計為 330 萬美元，中國市場預計複合年成長率為 19.0%

預計2024年美國主動脈復甦性血管內球囊阻斷市場規模將達330萬美元。作為世界第二大經濟體的中國，預計到2030年市場規模將達到570萬美元，在2024-2030年的分析期間內，複合年成長率為19.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為18.1%和17.5%。在歐洲，預計德國的複合年成長率約為14.9%。

全球復甦性主動脈血管內球囊阻斷市場—主要趨勢與促進因素摘要

為什麼復甦性主動脈血管內球囊阻斷術（REBOA）在創傷照護中變得如此受歡迎？

復甦性主動脈血管內球囊阻斷術 (REBOA) 已成為一種挽救生命的干涉措施，適用於因嚴重腹部、骨盆或下肢損傷而發生出血性休克的創傷患者。傳統上，如果這些病例無法控制出血，通常會立即進行開放性手術。然而，REBOA 提供了一種微創的替代方法，可以暫時控制出血並穩定患者病情，直到進行最終的手術治療，從而提高存活率。機動車事故、戰場傷病和工傷事故造成的創傷發生率不斷上升，推動了急診和軍事醫學對 REBOA 手術的需求。此外，血管通路技術的進步使此手術更加便捷，從而在創傷中心和院前急救中得到更廣泛的應用。

科技創新如何讓 REBOA 更有效、更安全？

基於導管的介入和血管內技術的創新顯著提高了REBOA手術的有效性和安全性。更小、更細的球囊導管的開發減少了與血管通路相關的併發症，並延長了閉塞時間。此外，即時影像導引和壓力監測系統可以更精確地放置和充氣球囊，從而最大限度地降低缺血性損傷的風險。具有無線監測功能的自動化REBOA系統也正在研究中，該系統允許臨床醫生遠端調整閉塞程度並最佳化灌注控制。這些技術進步使REBOA成為更可行、更安全的創傷管理方案，並將其臨床應用擴展到傳統的急救領域之外。

哪些市場趨勢推動了 REBOA 市場的擴張？

對創傷護理基礎設施建設的日益重視，推動了REBOA在民用和軍用醫療機構中的應用。 REBOA與院前急救服務（包括救護車和航空醫療運輸單位）的整合，進一步擴大了其應用範圍。此外，醫療機構正在投資REBOA培訓項目，旨在使創傷外科醫生、急診科醫生和重症加護團隊掌握有效執行該手術所需的技能。混合手術室和血管內創傷管理通訊協定的興起也推動了REBOA在三級醫療中心的廣泛應用。此外，旨在降低創傷死亡率的政府資助和研究計劃也支持了市場的成長。

REBOA 市場的主要成長動力是什麼？

全球REBOA市場的成長動力源於創傷相關死亡人數的增加、血管內球囊封堵技術的進步以及緊急創傷護理基礎設施的擴展。微創救生手術的普及，尤其是在軍事和民間創傷中心，進一步加速了市場需求。此外，正在進行的臨床研究旨在最佳化REBOA技術並將其應用擴展到產後出血等非創傷性疾病，這正在擴大市場潛力。人工智慧監測系統與機器人輔助血管手術的整合也有望提高REBOA的準確性和安全性，從而進一步推動市場擴張。隨著醫療保健系統優先考慮針對創傷患者的快速介入策略，REBOA市場正在徹底改變急診醫學領域，預計將實現顯著成長。

部分

最終用途（心臟麻痹、主動脈閉塞、戰術性戰鬥傷患護理）

受訪公司範例

Abbott Laboratories
Acandis GmbH
AngioDynamics, Inc.
Asahi Kasei Corporation
Bentley InnoMed GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
BVM Medical Limited
Cardinal Health, Inc.
Cook Medical
Edwards Lifesciences Corporation
Emergency Scientific, LLC
Front Line Medical Technologies
Johnson & Johnson
Lepu Medical Technology
Medtronic plc
Merit Medical Systems, Inc.
Mermaid Medical Group
MicroPort Scientific Corporation
Oscor Inc.

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

The global market for Resuscitative Endovascular Balloon Occlusion of the Aorta estimated at US$12.5 Million in the year 2024, is expected to reach US$37.2 Million by 2030, growing at a CAGR of 20.0% over the analysis period 2024-2030. Cardiac Arrest, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$21.7 Million by the end of the analysis period. Growth in the Aortic Occlusion segment is estimated at 23.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Million While China is Forecast to Grow at 19.0% CAGR

The Resuscitative Endovascular Balloon Occlusion of the Aorta market in the U.S. is estimated at US$3.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.7 Million by the year 2030 trailing a CAGR of 19.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.1% and 17.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.9% CAGR.

Global Resuscitative Endovascular Balloon Occlusion of the Aorta Market - Key Trends & Drivers Summarized

Why Is Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) Gaining Widespread Adoption in Trauma Care?

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) has emerged as a life-saving intervention for trauma patients experiencing hemorrhagic shock due to severe abdominal, pelvic, or lower extremity injuries. Traditionally, uncontrolled bleeding in such cases has been managed through immediate open surgery, but REBOA offers a minimally invasive alternative that improves survival rates by temporarily controlling hemorrhage and stabilizing patients until definitive surgical treatment can be performed. The increasing incidence of traumatic injuries from road accidents, battlefield injuries, and industrial accidents has driven the demand for REBOA procedures in emergency and military medicine. Additionally, advancements in vascular access technology have made the procedure more accessible, increasing its adoption across trauma centers and pre-hospital care settings.

How Are Technological Innovations Enhancing the Efficiency and Safety of REBOA?

Innovations in catheter-based interventions and endovascular technology have significantly improved the efficacy and safety of REBOA procedures. The development of smaller, lower-profile balloon catheters has reduced complications associated with vascular access and prolonged occlusion times. Additionally, real-time imaging guidance and pressure monitoring systems are enabling more precise placement and inflation of the balloon, minimizing the risk of ischemic injury. Automated REBOA systems with wireless monitoring capabilities are also being explored, allowing clinicians to remotely adjust occlusion levels and optimize perfusion control. These technological advancements are making REBOA a more viable and safer option for trauma management, expanding its clinical applications beyond traditional emergency settings.

What Market Trends Are Driving the Expansion of the REBOA Market?

The growing emphasis on improving trauma care infrastructure has led to increased adoption of REBOA in both civilian and military healthcare settings. The integration of REBOA into pre-hospital emergency services, including ambulance and air-medical transport units, is further expanding its reach. Additionally, medical institutions are investing in REBOA training programs to equip trauma surgeons, emergency physicians, and critical care teams with the necessary skills to perform the procedure effectively. The rise of hybrid operating rooms and endovascular trauma management protocols has also facilitated the wider adoption of REBOA in tertiary care centers. Moreover, government funding and research initiatives aimed at reducing mortality from traumatic injuries are supporting the market's growth.

What Are the Key Growth Drivers of the REBOA Market?

The growth in the global REBOA market is driven by increasing trauma-related fatalities, advancements in endovascular balloon occlusion technology, and the expansion of emergency trauma care infrastructure. The adoption of minimally invasive life-saving procedures, particularly in military and civilian trauma centers, has further accelerated demand. Additionally, ongoing clinical research into optimizing REBOA techniques and expanding its applications in non-trauma conditions, such as postpartum hemorrhage, is broadening its market potential. The integration of AI-powered monitoring systems and robotic-assisted vascular procedures is also expected to enhance the precision and safety of REBOA, fueling market expansion. As healthcare systems prioritize rapid intervention strategies for trauma patients, the REBOA market is poised for substantial growth, revolutionizing the field of emergency medicine.

SCOPE OF STUDY:

The report analyzes the Resuscitative Endovascular Balloon Occlusion of the Aorta market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Cardiac Arrest, Aortic Occlusion, Tactical Combat Casualty Care)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

Abbott Laboratories
Acandis GmbH
AngioDynamics, Inc.
Asahi Kasei Corporation
Bentley InnoMed GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
BVM Medical Limited
Cardinal Health, Inc.
Cook Medical
Edwards Lifesciences Corporation
Emergency Scientific, LLC
Front Line Medical Technologies
Johnson & Johnson
Lepu Medical Technology
Medtronic plc
Merit Medical Systems, Inc.
Mermaid Medical Group
MicroPort Scientific Corporation
Oscor Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Resuscitative Endovascular Balloon Occlusion of the Aorta - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Incidence of Traumatic Hemorrhage and Non-Compressible Bleeding Conditions Drives REBOA Adoption
- Increased Recognition of REBOA as a Life-Saving Pre-Hospital and Emergency Room Intervention Spurs Clinical Uptake
- Technological Advancements in Balloon Catheter Design Enhance Ease of Deployment and Procedural Speed
- Expansion of Trauma and Acute Care Surgery Programs Throws the Spotlight on Endovascular Resuscitation Devices
- Surge in Combat and Military Applications Strengthens Business Case for REBOA in Battlefield Medicine
- Regulatory Approvals for Low-Profile and Partial Occlusion Devices Expand Indication Spectrum
- Growth in Emergency Medicine Residency Training Supports Familiarity and Usage of REBOA Systems
- Integration of REBOA in Trauma Protocols and ATLS Guidelines Drives Hospital Adoption Rates
- Increased Utilization in Obstetric Hemorrhage and Ruptured Aneurysm Cases Expands Off-Label Applications
- Development of Zone-Specific Occlusion Strategies Enhances Targeted Hemodynamic Stabilization
- Partnerships Between Device Manufacturers and Trauma Centers Accelerate Product Validation and Usage
- Surging Demand for Hemorrhage Control in Civilian Mass Casualty Incidents Fuels Device Availability
- Adoption of Portable and Ultrasound-Guided REBOA Techniques Expands Pre-Hospital Intervention Capabilities
- OEM Investment in Simulation-Based Training Programs Promotes Safe Implementation Across Institutions
- Rising Emphasis on Damage Control Resuscitation Supports Complementary Role of REBOA With Surgical Interventions
- Improved Data From Prospective Trials Strengthens Clinical Confidence and Inclusion in Guidelines
- Use of REBOA in Hybrid Operating Rooms and Angio Suites Increases Workflow Integration
- Focus on Reducing Time-to-Intervention and Transport-Related Mortality Drives REBOA Training Among Paramedics
- Global Expansion of Advanced Trauma Systems Opens Market for REBOA in Developing Countries
- Adoption of Balloon Occlusion Techniques in Non-Traumatic Hemorrhagic Shock Supports Expanded Utility
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Resuscitative Endovascular Balloon Occlusion of the Aorta Market Analysis of Annual Sales in US$ for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
- TABLE 3: World 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Cardiac Arrest by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
- TABLE 5: World 6-Year Perspective for Cardiac Arrest by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 6: World Recent Past, Current & Future Analysis for Aortic Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
- TABLE 7: World 6-Year Perspective for Aortic Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Tactical Combat Casualty Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
- TABLE 9: World 6-Year Perspective for Tactical Combat Casualty Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 10: USA Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 11: USA 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
CANADA
- TABLE 12: Canada Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 13: Canada 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
JAPAN
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 14: Japan Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 15: Japan 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
CHINA
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 16: China Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 17: China 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
EUROPE
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 18: Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
- TABLE 19: Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
- TABLE 20: Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 21: Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
FRANCE
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 22: France Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 23: France 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
GERMANY
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 24: Germany Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 25: Germany 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
ITALY
- TABLE 26: Italy Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 27: Italy 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
UNITED KINGDOM
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 28: UK Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 29: UK 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
REST OF EUROPE
- TABLE 30: Rest of Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 31: Rest of Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
ASIA-PACIFIC
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 32: Asia-Pacific Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 33: Asia-Pacific 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
REST OF WORLD
- TABLE 34: Rest of World Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 35: Rest of World 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030